We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$514M
AUM Growth
-$3.94M
(-0.76%)
Cap. Flow
-$4.39M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
383
New
3
Increased
–
Reduced
1
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xenon Pharmaceuticals
XENE
|
+$276K |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$275K |
| 3 |
BSTG
Biostage, Inc. Common Stock
BSTG
|
+$122K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.05M |
| 2 |
LTM
LIFE TIME FITNESS INC
LTM
|
+$1.06M |
| 3 |
ARUN
ARUBA NETWORKS, INC.
ARUN
|
+$857K |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$662K |
| 5 |
AOL
AOL INC COMMON STOCK
AOL
|
+$240K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 14.38% |
| 4 | Industrials | 11.7% |
| 5 | Consumer Discretionary | 8.39% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q2 2015 Portfolio in Review
As of Q2 2015, NJ State Employees Deferred Compensation Plan held 383 positions worth $514M, down 0.76% from $518M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 2.3%. NJ State Employees Deferred Compensation Plan opened 3 new positions and exited 6, leaving the 383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- NJ State Employees Deferred Compensation Plan's largest Q2 2015 buy was Xenon Pharmaceuticals: 20,000 shares worth $231K.
- NJ State Employees Deferred Compensation Plan's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $3.43K.
- NJ State Employees Deferred Compensation Plan fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.05M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $514M portfolio in Q2 2015.
- NJ State Employees Deferred Compensation Plan opened 3 new positions and closed 6 in Q2 2015.
- NJ State Employees Deferred Compensation Plan's portfolio value fell 0.76% quarter-over-quarter to $514M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2015, filed 6 Aug 2015.